Serving To Educate Primary Care Clinicians On Respiratory Issues
Evidence Based Medicine Header 1
Medical Education Header 2
Peer-to-peer Exchange Header 3
Metabolic Diseases Header 4
News: Articles from our Partners at Consultant 360 December 2019

New Respiratory Disease Articles from our Partners at Consultant 360

CDC Releases New Vaping-Related Lung Injury Guidance

http://bit.ly/2rHGrnH

The Centers for Disease Control and Prevention has release two reports concerning vaping and e-cigarette, or vaping, product use–associated lung injury.

CDC: US Cigarette Smoking Hits All-Time Low

http://bit.ly/34HUyYS

In order to examine national estimates of tobacco product use, the CDC, Food and Drug Administration, and the National Cancer Institute analyzed data from the 2018 National Health Interview Survey.

New Guidelines for Drug-Resistant TB Treatment

http://bit.ly/2OIznjy

The ATS, CDC, ERS, and IDSA have developed practice guidelines that include 25 recommendations on the treatment of drug-resistant tuberculosis, including multidrug-resistant TB and isoniazid-resistant but rifampin-susceptible TB.

OSA Affects BP in Dose-Response Association

http://bit.ly/2RcAjPa

Studies assessing the prevalence and characteristics of the association between obstructive sleep apnea and poor blood pressure control in patients with resistant hypertension are limited. A new study sheds light.

CPAP vs NIV: Which Is a Better First-Line Treatment For OHS?

http://bit.ly/2LetMQ5

Because the preferred positive airway pressure therapy method for treating obesity hypoventilation syndrome is unclear, a panel of experts compared the effectiveness of CPAP vs noninvasive ventilation as a first-line treatment and made a new recommendation for which to initiate.